PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neurology, Medical University of Lublin, Lublin, Poland. Electronic address: k.rejdak@umlub.pl.\', \'Department of Experimental Pharmacology, Medical Research Center, Polish Academy of Sciences, Warsaw, Poland. Electronic address: pgrieb@imdik.pan.pl.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2211-0348(20)30239-X10.1016/j.msard.2020.102163
?:hasPublicationType
?:journal
  • Multiple sclerosis and related disorders
is ?:pmid of
?:pmid
?:pmid
  • 32388458
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.123
?:rankingScore_hIndex
  • 18
?:title
  • Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all